| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CVX | Common Stock | Options Exercise | $1,044,000 | +9,000 | +1349% | $116.00 | 9,667 | 25 Feb 2022 | Direct | F1 |
| transaction | CVX | Common Stock | Options Exercise | $1,832,380 | +22,000 | +228% | $83.29 | 31,667 | 25 Feb 2022 | Direct | F1 |
| transaction | CVX | Common Stock | Sale | $4,340,000 | -31,000 | -98% | $140.00 | 667 | 25 Feb 2022 | Direct | F1 |
| holding | CVX | Common Stock | 4,939 | 25 Feb 2022 | by 401(k) plan | ||||||
| holding | CVX | Common Stock | 1,880 | 25 Feb 2022 | UK benefits plan |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CVX | Non-Qualified Stock Option (Right to Buy) | Options Exercise | $0 | -9,000 | -50% | $0.000000 | 9,000 | 25 Feb 2022 | Common Stock | 9,000 | $116.00 | Direct | F2 |
| transaction | CVX | Non-Qualified Stock Option (Right to Buy) | Options Exercise | $0 | -22,000 | -32% | $0.000000 | 47,700 | 25 Feb 2022 | Common Stock | 22,000 | $83.29 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2021. |
| F2 | Option granted 1/29/2014. One-third of the shares subject to the option vested on each of the first, second and third anniversaries of the date of grant. |
| F3 | Option granted 1/27/2016. One-third of the shares subject to the option vested on each of the first, second and third anniversaries of the date of grant. |